Interstitial Lung Diseases in Respiratory ICU

This is Prospective observational study to analyze the clinical features, risk factors, outcome,mortality rates in interstitial lung diseases patients who required admission in Respiratory ICU

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Interstitial Lung Diseases Lung Diseases Lung Diseases, Interstitial Respiratory Tract Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who had diagnosis of interstitial lung diseases required admission in respiratory ICU

Exclusion criteria

Patients with respiratory diseases other than ILD

Treatment and study plan

Primary outcomes

Number of participants with Complications of disease

Time frame: 1 month after icu admission
Evaluate Length of respiratory ICU stay

Time frame: 1 month after icu admission
Assess mortality of patients with interstitial lung diseases in respiratory icu.

Time frame: 1 month after icu admission

Study contacts

Contact information is provided by the study sponsor or research team.

yasmine mamdouh salah, resident

CONTACT

[email protected]

+201092243838

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Factors Affecting Outcome of Patients With Interstitial Lung Diseases in Respiratory Intensive Care Unit

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2026
First posted: Aug 12, 2025
Registry last updated: Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting